Clinical trial
Randomised Study Comparing 6 And 8 Cycles Of Chemotherapy With CHOP ( Cyclophosphamide, Doxorubicin, Vincristine And Prednisone) At 14-Day Intervals (CHOP-14), Both With Or Without The Monoclonal Anti-CD20 Antibody Rituximab In Patients Aged 61 To 80 Years With Aggressive Non-Hodgkin's Lymphoma
NCT00052936 is registered in ClinicalTrials.gov with German High-Grade Non-Hodgkin's Lymphoma Study Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Study Comparing 6 And 8 Cycles Of Chemotherapy With CHOP ( Cyclophosphamide, Doxorubicin, Vincristine And Prednisone) At 14-Day Intervals (CHOP-14), Both With Or Without The Monoclonal Anti-CD20 Antibody Rituximab In Patients Aged 61 To 80 Years With Aggressive Non-Hodgkin's Lymphoma
- Lead sponsor
- German High-Grade Non-Hodgkin's Lymphoma Study Group
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2001
- Completion date
- August 5, 2010
- Enrollment
- 1,506 (actual)
- Sites
- 174
Conditions
As the registry lists them; a condition with its own page is linked.